These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35891212)

  • 1. Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India.
    Achrekar GC; Batra K; Urankar Y; Batra R; Iqbal N; Choudhury SA; Hooda D; Khan R; Arora S; Singh A; Chirico F; Sharma M
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study.
    Yadete T; Batra K; Netski DM; Antonio S; Patros MJ; Bester JC
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Booster Vaccination Hesitancy in the United States: A Multi-Theory-Model (MTM)-Based National Assessment.
    Batra K; Sharma M; Dai CL; Khubchandani J
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Social Attitudes Towards the Booster Dose of the COVID-19 Vaccine and the Associated Factors Among Residents of Riyadh, Saudi Arabia.
    Alyahya K; Almousa WY; Binsalamh LF; Alturaifi GA; Alabdely LH; Aljulaihim NF; Aldosari LM
    Cureus; 2023 Oct; 15(10):e46556. PubMed ID: 37933360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community Level Correlates of COVID-19 Booster Vaccine Hesitancy in the United States: A Cross-Sectional Analysis.
    Krasner H; Harmon N; Martin J; Olaco CA; Netski DM; Batra K
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400150
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey.
    Krishna E; Karthikeyan V; Ahmad S; Ranjan A; Hasan Km A; Pandey S; Kumar P; Singh CM
    Cureus; 2023 Nov; 15(11):e49363. PubMed ID: 38146559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India.
    Sharma N; Basu S; Lalwani H; Rao S; Malik M; Garg S; Shrivastava R; Singh MM
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley.
    Lee KW; Yap SF; Ong HT; Liew SL; Oo M; Swe KMM
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants.
    Abouzid M; Ahmed AA; El-Sherif DM; Alonazi WB; Eatmann AI; Alshehri MM; Saleh RN; Ahmed MH; Aziz IA; Abdelslam AE; Omran AA; Omar AA; Ghorab MA; Islam SMS
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.
    Al-Qerem W; Jarab A; Hammad A; Alsajri AH; Al-Hishma SW; Ling J; Alabdullah AS; Salama A; Mosleh R
    Patient Prefer Adherence; 2022; 16():1525-1537. PubMed ID: 35769339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
    Allen K; Lambert SB; Yuen A; Pourmarzi D
    BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study.
    Al-Qerem W; Al Bawab AQ; Hammad A; Ling J; Alasmari F
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Hum Vaccin Immunother; 2022 Nov; 18(6):2099210. PubMed ID: 35880816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
    Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
    J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Rollout and Initial Uptake of a Booster COVID-19 Vaccine Among Israel Defense Forces Soldiers.
    Talmy T; Nitzan I
    J Prev (2022); 2023 Feb; 44(1):1-14. PubMed ID: 35972594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population.
    Ayyalasomayajula S; Dhawan A; Karattuthodi MS; Thorakkattil SA; Abdulsalim S; Elnaem MH; Sridhar S; Unnikrishnan MK
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.
    Zhou Y; Li GX; Zhao TS; Du J; Zhang WX; Xie MZ; Chen LY; Zeng J; Wang C; Liu B; Liu YQ; Cui F; Lu QB
    J Med Virol; 2023 Jan; 95(1):e28256. PubMed ID: 36305477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
    Shehab M; Alrashed F; Alfadhli A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.